Cardiol Therapeutics Inc T.CRDL

Cardiol Omicron

[Bullknit101]

As Omicron spreads like wildfire and hospitalizations increase, it is highly likely Cardiol Rx will be fast tracked. Retail investors have short memories but this is going to be huge: "High-risk patients with Cardiovascular Disease (CVD), hospitalized with COVID-19 CardiolRx Cardiol has received approval from the U.S. Food and Drug Administration for its Investigational New Drug application to conduct a Phase II/III clinical trial investigating the efficacy and safety of CardiolRx in the treatment of hospitalized COVID-19 patients with a prior history of, or risk factors for, cardiovascular disease".

[NewFanCBD]

Good point! These are bargain basement prices here. When people catch on, this could really run. 

[Youhillman]

Don't necessarily disagree with you Bullknit101 however the FDA trials for Covid started in May and were to be completed by the end of this year with results announced in Q1 2022. I guess what's concerning to me, is that Cardiol was to announce when they were halfway through the LANCER trials and that has not happened yet. With all the Covid cases in the US over the past 6 months

[Youhillman]

Covid Lancer trials have been pushed back 6 months, no explanation given by Cardiol so Bullknit101, it doesn't appear as if this is being fast tracked at all! Disappointing for sure!